124 related articles for article (PubMed ID: 32798925)
1. Consumption in contrast: The politics of comparison in healthcare practitioners' accounts of men who inject performance and image-enhancing drugs.
Seear K; Moore D; Fraser S; Fomiatti R; Aitken C
Int J Drug Policy; 2020 Nov; 85():102883. PubMed ID: 32798925
[TBL] [Abstract][Full Text] [Related]
2. Is another relationship possible? Connoisseurship and the doctor-patient relationship for men who consume performance and image-enhancing drugs.
Fraser S; Fomiatti R; Moore D; Seear K; Aitken C
Soc Sci Med; 2020 Feb; 246():112720. PubMed ID: 31972378
[TBL] [Abstract][Full Text] [Related]
3. Maintaining the healthy body: Blood management and hepatitis C prevention among men who inject performance and image-enhancing drugs.
Fomiatti R; Lenton E; Latham JR; Fraser S; Moore D; Seear K; Aitken C
Int J Drug Policy; 2020 Jan; 75():102592. PubMed ID: 31855731
[TBL] [Abstract][Full Text] [Related]
4. Social suppliers: Exploring the cultural contours of the performance and image enhancing drug (PIED) market among bodybuilders in the Netherlands and Belgium.
van de Ven K; Mulrooney KJ
Int J Drug Policy; 2017 Feb; 40():6-15. PubMed ID: 27574781
[TBL] [Abstract][Full Text] [Related]
5. Information sought, information shared: exploring performance and image enhancing drug user-facilitated harm reduction information in online forums.
Tighe B; Dunn M; McKay FH; Piatkowski T
Harm Reduct J; 2017 Jul; 14(1):48. PubMed ID: 28732534
[TBL] [Abstract][Full Text] [Related]
6. Health risk and health seeking behaviours among people who inject performance and image enhancing drugs who access needle syringe programs in Australia.
Van de Ven K; Maher L; Wand H; Memedovic S; Jackson E; Iversen J
Drug Alcohol Rev; 2018 Nov; 37(7):837-846. PubMed ID: 29968372
[TBL] [Abstract][Full Text] [Related]
7. Men, bodywork, health and the potentiality of performance and image-enhancing drugs.
Dowsett GW; Duncan D; Waling A; Angelides S; Nourse G
Health Sociol Rev; 2023 Nov; 32(3):341-356. PubMed ID: 36577038
[TBL] [Abstract][Full Text] [Related]
8. Steroid users and the unique challenge they pose to needle and syringe program workers.
Dunn M; McKay FH; Iversen J
Drug Alcohol Rev; 2014 Jan; 33(1):71-7. PubMed ID: 24400704
[TBL] [Abstract][Full Text] [Related]
9. Health care engagement behaviors of men who use performance- and image-enhancing drugs in Australia.
Jacka B; Larance B; Copeland J; Burns L; Farrell M; Jackson E; Degenhardt L
Subst Abus; 2020; 41(1):139-145. PubMed ID: 31545138
[No Abstract] [Full Text] [Related]
10. Investigating the impact of COVID-19 on performance and image enhancing drug use.
Dunn M; Piatkowski T
Harm Reduct J; 2021 Dec; 18(1):124. PubMed ID: 34863199
[TBL] [Abstract][Full Text] [Related]
11. Do performance and image enhancing drug users in regional Queensland experience difficulty accessing health services?
Dunn M; Henshaw R; McKay FH
Drug Alcohol Rev; 2016 Jul; 35(4):377-82. PubMed ID: 26644363
[TBL] [Abstract][Full Text] [Related]
12. Performance and image enhancing drug interventions aimed at increasing knowledge among healthcare professionals (HCP): reflections on the implementation of the Dopinglinkki e-module in Europe and Australia in the HCP workforce.
Atkinson AM; van de Ven K; Cunningham M; de Zeeuw T; Hibbert E; Forlini C; Barkoukis V; Sumnall HR
Int J Drug Policy; 2021 Sep; 95():103141. PubMed ID: 33549466
[TBL] [Abstract][Full Text] [Related]
13. Across the spectrum of legality: The market activities of influencers specialized in steroids and other performance and image enhancing drugs.
Paoli L; Joseph Cox LT
Int J Drug Policy; 2024 Jan; 123():104246. PubMed ID: 37979285
[TBL] [Abstract][Full Text] [Related]
14. Masculine enhancement as health or pathology: gender and optimisation discourses in health promotion materials on performance and image-enhancing drugs (PIEDs).
Nourse G; Fraser S; Moore D
Health Sociol Rev; 2024 Jan; ():1-17. PubMed ID: 38286142
[TBL] [Abstract][Full Text] [Related]
15. Masculinities, practices and meanings: A critical analysis of recent literature on the use of performance- and image-enhancing drugs among men.
Moore D; Hart A; Fraser S; Seear K
Health (London); 2020 Nov; 24(6):719-736. PubMed ID: 30922123
[TBL] [Abstract][Full Text] [Related]
16. Performance and image enhancing drug injectors' access to needle syringe programs: Responding to a public policy dilemma.
van Beek I; Chronister KJ
Int J Drug Policy; 2015 Sep; 26(9):868-74. PubMed ID: 26118797
[TBL] [Abstract][Full Text] [Related]
17. The patient experience of patient-centered communication with nurses in the hospital setting: a qualitative systematic review protocol.
Newell S; Jordan Z
JBI Database System Rev Implement Rep; 2015 Jan; 13(1):76-87. PubMed ID: 26447009
[TBL] [Abstract][Full Text] [Related]
18. Injecting risk behaviour and related harm among men who use performance- and image-enhancing drugs.
Larance B; Degenhardt L; Copeland J; Dillon P
Drug Alcohol Rev; 2008 Nov; 27(6):679-86. PubMed ID: 18825549
[TBL] [Abstract][Full Text] [Related]
19. Exploring the relationship between online buyers and sellers of image and performance enhancing drugs (IPEDs): Quality issues, trust and self-regulation.
van de Ven K; Koenraadt R
Int J Drug Policy; 2017 Dec; 50():48-55. PubMed ID: 29028563
[TBL] [Abstract][Full Text] [Related]
20. Performance- and image-enhancing drug use in the community: use prevalence, user demographics and the potential role of wastewater-based epidemiology.
Shimko KM; Piatkowski T; Thomas KV; Speers N; Brooker L; Tscharke BJ; O'Brien JW
J Hazard Mater; 2021 Oct; 419():126340. PubMed ID: 34171672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
